JNNP Podcast
BMJ Group
JNNP’s ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS.
Categories: Health
Listen to the last episode:
How often do movement disorder specialists agree when classifying tics? A recent study published in JNNP explores this question with a two-stage approach, seeking a diagnosis from experts first based on video evidence alone and then following the provision of additional clinical data. The study's last author, Dr. Christos Ganos (1), joins host Dr. Saima Chaudhry (2) to discuss the results. Read the paper here: "Distinguishing functional from primary tics: a study of expert video assessments" Related links: European Society for the Study of Tourette Syndrome 2022 criteria for clinical diagnosis of functional tic-like behaviours: International consensus from experts in tic disordershttps://onlinelibrary.wiley.com/doi/10.1111/ene.15672 Tics and functional tic-like movements: can we tell them apart?https://www.neurology.org/doi/10.1212/WNL.0000000000008372 (1) Department of Neurology (C.G.), Charité University Medicine Berlin, Germany(2) Warren Alpert Medical School, Brown University, Rhode Island, USA Please subscribe to the show on Apple Podcasts, Spotify or find it on your platform of choice. Your feedback and reviews are very appreciated. Follow JNNP on twitter: @JNNP_BMJ
Previous episodes
-
316 - Distinguishing primary from functional tics Mon, 19 Feb 2024 - 0h
-
315 - Nitrous Oxide Abuse Fri, 22 Sep 2023 - 0h
-
314 - Brain Fog Demystified Tue, 08 Aug 2023 - 0h
-
313 - A roadmap to ALS prevention: strategies and priorities Thu, 15 Jun 2023 - 0h
-
312 - MOGAD: Definition, diagnosis and treatment Mon, 15 May 2023 - 0h
-
311 - CGRP in migraine: current therapeutics, future implications and potential off-target effects Tue, 21 Dec 2021 - 0h
-
310 - Alemtuzumab’s impact on functional and structural integrity of the visual system in MS Wed, 17 Nov 2021 - 0h
-
309 - Emotional processing in functional neurological disorder (FND) Wed, 12 Jun 2019 - 0h
-
308 - Can cocoa help with fatigue in MS Tue, 28 May 2019 - 0h
-
307 - Neurorehabilitation in chronic stroke Wed, 08 May 2019 - 0h
-
306 - The real patient value Thu, 18 Apr 2019 - 0h
-
305 - Medical conferences - what do we get out of them? Thu, 04 Apr 2019 - 0h
-
304 - Oral immunotherapies in MS a comparison of efficacy. Mon, 25 Mar 2019 - 0h
-
303 - Therapeutic trial design in frontotemporal dementias Wed, 20 Mar 2019 - 0h
-
302 - Do genes affect age of onset in ALS? Mon, 11 Mar 2019 - 0h
-
301 - The lifetime risk of common neurological disorders in the elderly population Mon, 18 Feb 2019 - 0h
-
300 - PMA and PLS: are they really restricted phenotypes? Mon, 04 Feb 2019 - 0h
-
299 - Statins and the risk of recurrent intracerebral haemorrhage (ICH) – what does the evidence say? Mon, 21 Jan 2019 - 0h
-
298 - Functional impairment and improvement Mon, 10 Dec 2018 - 0h
-
297 - Can computational models help us understand complex movement disorders? Mon, 29 Oct 2018 - 0h
-
296 - Idiopathic intracranial hypertension: guidelines for diagnosis and management Mon, 08 Oct 2018 - 0h
-
295 - Nusinersen for SMA Wed, 29 Aug 2018 - 0h
-
294 - Expanding clinical spectrums in both Kennedy’s disease and poststroke syndromes Mon, 06 Aug 2018 - 0h
-
293 - The use of cannabis in epilepsy, and surgery for tremor Mon, 02 Jul 2018 - 0h
-
292 - Epilepsy an evidence update Thu, 31 May 2018 - 0h
-
291 - Evolution or revolution? Should we re-think clinical practice? Mon, 30 Apr 2018 - 0h
-
290 - The Use of Frankincense Extract In MS Wed, 04 Apr 2018 - 0h
-
289 - A new questionnaire to measure quality of life in inflammatory neuropathies Wed, 07 Mar 2018 - 0h
-
288 - Marriage and a reduced risk of dementia Wed, 28 Feb 2018 - 0h
-
287 - Anti-inflammatory approaches to stroke prevention; monitoring disease progression in ALS Thu, 08 Feb 2018 - 0h
-
286 - Nodes and paranodes; alternative treatments in MS Fri, 26 Jan 2018 - 0h
-
285 - Pathophysiology of functional neurological disorder Wed, 13 Dec 2017 - 0h
-
284 - Is methamphetamine use linked to stroke in young adults? Tue, 28 Nov 2017 - 0h
-
283 - Cerebral Amyloid Angiopathy: New Insights For Clinical Practice Wed, 08 Nov 2017 - 0h
-
282 - Cortical Influences in ALS Tue, 31 Oct 2017 - 0h
-
281 - Intravenous immunoglobulin in CIDP Mon, 23 Oct 2017 - 0h
-
280 - Complex inherited neuropathies: a new approach to diagnosis? Wed, 18 Oct 2017 - 0h
-
279 - Cerebellum and neurodegeneration; autoantibodies and psychological development in children Mon, 04 Sep 2017 - 0h
-
278 - Time Matters - part 2: how the real costs of multiple sclerosis are being concealed Mon, 07 Aug 2017 - 0h
-
277 - Survival and cause of death in Multiple Sclerosis Wed, 19 Jul 2017 - 0h
-
276 - Time Matters - part 1: delay is “expensive” in all aspects of multiple sclerosis Mon, 10 Jul 2017 - 0h
-
275 - Seven tesla MRI In Neurodegenerative Dementias Fri, 16 Jun 2017 - 0h
-
274 - Conversational Laughter In Dementia Fri, 05 May 2017 - 0h
-
273 - Narrative and Neurology: The Andrew Lees Experiment Thu, 06 Apr 2017 - 0h
-
272 - April 2017: deconstructing dilemmas in Amyotrophic Lateral Sclerosis and Guillain-Barré Syndrome Mon, 27 Mar 2017 - 0h
-
271 - Zika virus and Guillain-Barré Syndrome: what do we know? Mon, 13 Mar 2017 - 0h
-
270 - Immunomodulatory therapy in advanced multiple sclerosis Mon, 13 Feb 2017 - 0h
-
269 - The relationship between orthostatic hypotension and cognitive impairment in α-synucleinopathies Wed, 30 Nov 2016 - 0h
-
268 - A clinical tool for predicting survival in motor neurone disease Wed, 30 Nov 2016 - 0h
-
267 - Latitude and disease severity in Multiple Sclerosis Tue, 15 Nov 2016 - 0h